PMC Articles for MedGen (Select 66772) - PMC

Links from MedGen

Items: 1 to 20 of 1222

<< First< Prev

Page of 62

Select item 44906271.

Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma: The American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma

Samuel A. Wells, Jr., Sylvia L. Asa, Henning Dralle, Rossella Elisei, Douglas B. Evans, Robert F. Gagel, Nancy Lee, Andreas Machens, Jeffrey F. Moley, Furio Pacini, Friedhelm Raue, Karin Frank-Raue, Bruce Robinson, M. Sara Rosenthal, Massimo Santoro, Martin Schlumberger, Manisha Shah, Steven G. Waguespack

Thyroid. 2015 Jun 1; 25(6): 567–610. doi: 10.1089/thy.2014.0335

PMCID:: PMC4490627

Article PubReader PDF–1.1M Cite

Select item 34190072.

The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma & Medullary Thyroid Cancer

Herbert Chen, Rebecca S. Sippel, Karel Pacak

Pancreas. Author manuscript; available in PMC 2012 Aug 14.

Published in final edited form as: Pancreas. 2010 Aug; 39(6): 775–783. doi: 10.1097/MPA.0b013e3181ebb4f0

PMCID:: PMC3419007

Article PubReader PDF–315K Cite

Select item 105114423.

Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy

Hyunju Park, Hyun Jin Ryu, Jung Heo, Man Ki Chung, Young Ik Son, Jung-Han Kim, Soo Yeon Hahn, Jung Hee Shin, Young Lyun Oh, Sun Wook Kim, Jae Hoon Chung, Jee Soo Kim, Tae Hyuk Kim

Sci Rep. 2023; 13: 15663. Published online 2023 Sep 20. doi: 10.1038/s41598-023-42907-3

PMCID:: PMC10511442

Article PubReader PDF–1.1M Cite

Select item 105102764.

Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value

Anna Citarella, Zein Mersini Besharat, Sofia Trocchianesi, Tanja Milena Autilio, Antonella Verrienti, Giuseppina Catanzaro, Elena Splendiani, Zaira Spinello, Silvia Cantara, Patrizia Zavattari, Eleonora Loi, Cristina Romei, Raffaele Ciampi, Luciano Pezzullo, Maria Grazia Castagna, Antonio Angeloni, Rosella Elisei, Cosimo Durante, Agnese Po, Elisabetta Ferretti

Biomark Res. 2023; 11: 82. Published online 2023 Sep 19. doi: 10.1186/s40364-023-00522-4

PMCID:: PMC10510276

Article PubReader PDF–1017K Cite

Select item 104672555.

Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer, and RET-mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial

Shun Lu, Xiangqian Zheng, Yuping Sun, Dingzhi Huang, Lin Wu, Qinghai Ji, Chengzhi Zhou, Jianying Zhou, Ye Guo, Minghua Ge, Ding Ding, Jingxin Shao, Wanli Zhang, Ming Gao, Ying Cheng

Ther Adv Med Oncol. 2023; 15: 17588359231189429. Published online 2023 Aug 25. doi: 10.1177/17588359231189429

PMCID:: PMC10467255

Article PubReader PDF–4.8M Cite

Select item 104666786.

Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up

Fatemeh Rahmani, Maryam Tohidi, Farid Azmoudeh-Ardalan, Amir Sadeghi, Farzad Hadaegh

BMC Endocr Disord. 2023; 23: 186. Published online 2023 Aug 30. doi: 10.1186/s12902-023-01439-7

PMCID:: PMC10466678

Article PubReader PDF–1.4M Cite

Select item 104530387.

Different RONS Generation in MTC-SK and NSCL Cells Lead to Varying Antitumoral Effects of Alpha-Ketoglutarate + 5-HMF

Joachim Greilberger, Katharina Erlbacher, Philipp Stiegler, Reinhold Wintersteiger, Ralf Herwig

Curr Issues Mol Biol. 2023 Aug; 45(8): 6503–6525. Published online 2023 Aug 7. doi: 10.3390/cimb45080410

PMCID:: PMC10453038

Article PubReader PDF–2.5M Cite

Select item 104393268.

RATIONALE FOR THE APPLICATION OF CALCITONIN LEVEL IN THE EARLY POSTOPERATIVE PERIOD TO EVALUATE THE EFFECTIVENESS OF SURGICAL TREATMENT OF MEDULLARY THYROID CANCER

O.A. Tovkai, V.O. Palamarchuk, O.V. Shidlovskyi, V.O. Shidlovskyi, V.V. Kuts, VA Smoliar, M.I. Sheremet, R.D. Levchuk, I.I. Morozovych, D. Cretoiu, O.V. Lazaruk

Acta Endocrinol (Buchar) 2023 Jan-Mar; 19(1): 142–146. Published online 2023 Aug 14. doi: 10.4183/aeb.2023.142

PMCID:: PMC10439326

Article PubReader PDF–417K Cite

Select item 104174299.

From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer

Claudia Ricci, Antonia Salvemini, Cristina Dalmiglio, Maria Grazia Castagna, Silvia Cantara

Cancers (Basel) 2023 Aug; 15(15): 4009. Published online 2023 Aug 7. doi: 10.3390/cancers15154009

PMCID:: PMC10417429

Article PubReader PDF–1.4M Cite

Select item 1041729810.

A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma

Chijioke Nze, Pavlos Msaouel, Mohamed H. Derbala, Bettzy Stephen, Abdulrahman Abonofal, Funda Meric-Bernstam, Nizar M. Tannir, Aung Naing

Cancers (Basel) 2023 Aug; 15(15): 3806. Published online 2023 Jul 27. doi: 10.3390/cancers15153806

PMCID:: PMC10417298

Article PubReader PDF–6.8M Cite

Select item 1040917711.

基础血清降钙素值对甲状腺髓样癌的鉴别诊断价值

茜辉刘, 鑫聂, 勇贺, 梦婷银, 贵星李

Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar 20; 54(2): 432–438. Chinese. doi: 10.12182/20230160513

PMCID:: PMC10409177

Article PubReader PDF–1.2M Cite

Select item 1038173512.

Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments

Rui Sousa Martins, Tito Teles Jesus, Luís Cardoso, Paula Soares, João Vinagre

J Pers Med. 2023 Jul; 13(7): 1132. Published online 2023 Jul 13. doi: 10.3390/jpm13071132

PMCID:: PMC10381735

Article PubReader PDF–924K Cite

Select item 1037425213.

Partial preservation of the normal thyroid gland based on tumor diameter may be possible in small medullary thyroid carcinoma: a two-center 15-year retrospective study

Guiming Fu, Xiaoyi Li, Fengli Guo, Xianhui Ruan, Wei Zhang, Weijing Zhang, Yaping Zhang, Yibo Chen, Chunhua Li, Jin Chen, Xiangqian Zheng, Zhaohui Wang, Ming Gao

Front Oncol. 2023; 13: 1216394. Published online 2023 Jul 13. doi: 10.3389/fonc.2023.1216394

PMCID:: PMC10374252

Article PubReader PDF–955K Cite

Select item 1036490614.

Complications after medullary thyroid carcinoma surgery: multicentre study of the SQRTPA and EUROCRINE^® databases

D ‐J van Beek, M Almquist, A O Bergenfelz, T J Musholt, E Nordenström, the EUROCRINE® Council

Br J Surg. 2021 Jun; 108(6): 691–701. Published online 2021 May 18. doi: 10.1093/bjs/znaa195

PMCID:: PMC10364906

Article PubReader PDF–424K Cite

Select item 1035812815.

Extended RET Gene Analysis in Patients with Apparently Sporadic Medullary Thyroid Cancer: Clinical Benefits and Cost

Susan C. Lindsey, Ilda S. Kunii, Fausto Germano-Neto, Misaki Y. Sittoni, Cléber P. Camacho, Flávia O. F. Valente, Ji H. Yang, Priscila S. Signorini, Rosana Delcelo, Janete M. Cerutti, Rui M. B. Maciel, Magnus R. Dias-da-Silva

Horm Cancer. 2012 Aug; 3(4): 181–186. Published online 2012 May 31. doi: 10.1007/s12672-012-0109-7